Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
- Demonstrate the superiority of combination of vildagliptin 50mg bid and metformin over metformin monotherapy in treatment-naive patients with T2DM by testing the hypothesis that the risk of initial treatment failure (defined as HbA1c ≥ 7.0%) is lower with the combination of vildagliptin and metformin compared to that with metformin monotherapy - Demonstrate the long-term efficacy of combination of Vildagliptin 50mg bid and metformin over metformin monotherapy in treatment-naive patients with T2DM by testing the hypothesis that the rate of loss in glycemic control over time (estimated annualized slope of HbA1c over time using a random coefficient model) is lower with the combination vildagliptin plus metformin compared to that with metformin monotherapy
Inclusion criteria
- Type 2 diabetes mellitus